|
Cost-utility analyses |
||
| Alternatives |
Usual care |
Usual care plus exercise |
|
|
||
| EQ-5D utility at baselinea |
0.331 (0.150 to 0.511) |
0.316 (0.162 to 0.470) |
| EQ-5D utility at 3 monthsa |
0.334 (0.175 to 0.494) |
0.582 (0.434 to 0.729) |
| EQ-5D utility at 8 monthsa |
0.334 (0.175 to 0.493) |
0.528 (0.380 to 0.675) |
| QALY over 8 monthsb |
0.002 (-0.087 to 0.091) |
0.133 (0.034 to 0.231) |
| QALY difference vs. usual carec |
0.131 (0.011 to 0.290) |
|
| Health system perspective: |
||
| Incremental cost/person (€) |
517 |
|
| Cost-utility (€/QALY)c |
3,947 (1,782 to 47,000) |
|
| Societal perspective: |
||
| Incremental cost/person (€) |
1,032 |
|
| Cost-utility (€/QALY) ‡ |
7,878 (3,559 to 93,818) |
|
|
QALY, quality adjusted life year. aMean (95% confidence interval) estimated by analysis of covariance with adjustment for baseline EQ-5D score and then rounded to 3 significant figures; bmean (95% confidence interval) using the area under the curve technique; cmean (95% confidence interval estimated by bootstrapping) using the area under the curve technique. | ||
Gusi and Tomas-Carus Arthritis Research & Therapy 2008 10:R24 doi:10.1186/ar2377 |
||